Therapeutic management of gestational diabetes

Diabetes and Metabolism

Volumn 36, Issue 6, 2010, Pages 658-671

  Jacqueminet, S ^a   Jannot Lamotte, M F ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MANAGEMENT; FEMALE; HUMAN; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW; RISK FACTOR;

DIABETES, GESTATIONAL; DISEASE MANAGEMENT; FEMALE; HUMANS; PREGNANCY; RISK FACTORS;

MLCS; MLOWN;

EID: 79953720940     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.11.016     Document Type: Article

References (121)

1. Cutchie, W.A., Cheung, N.W., Simmons, D., Comparison of international and New Zealand guidelines for the care of pregnant women with diabetes. Diabet Med 23 (2006), 460–468.
2. Yogev, Y., Ben-Haroush, A., Chen, R., Rosenn, B., Hod, M., Langer, O., Diurnal glycemic profi le in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol 191 (2004), 949–953.
3. Parretti, E., Mecacci, F., Papini, M., Cioni, R., Carignani, L., Mignosa, M., et al. Third-trimester maternal glucose levels from diurnal profi les in nondiabetic pregnancies: correlation with sonographic parameters of fetal growth. Diabetes Care, 2001, 241319–241323.
4. Siegmund, T., Rad, N.T., Ritterath, C., Siebert, G., Henrich, W., Buhling, K.J., Longitudinal changes in the continuous glucose profi le measured by the CGMS in healthy pregnant women and determination of cut-off values. Euro J Obstet Gynecol Reprod Biol 139 (2008), 46–52.
5. Rowan, J.A., Gao, W., Hague, W.M., McIntyre, H.D., Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care 33 (2010), 9–16.
6. Langer, O., Levy, J., Brustman, L., Anyaegbunam, A., Merkatz, R., Divon, M., Glycemic control in gestational diabetes mellitus-how tight is tight enough: small for gestational age versus large for gestational age?. Am J Obstet Gynecol 161 (1989), 646–653.
7. Crowther, C.A., Hiller, J.E., Moss, J.R., McPhee, A.J., Jeffries, W.S., Robinson, JS, for the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352 (2005), 2477–2486.
8. Landon, M.B., Spong, C.Y., Thom, E., Carpenter, M.W., Ramin, S.M., Casey, B., et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361 (2009), 1339–1348.
9. Verier-Mine, O., Timsit, J., What are the different modalities for the therapeutic management of gestational diabetes?. Diabetes Metab 23:Suppl 5 (1997), 30–33.
10. HAPO Study Cooperative Research Group, Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358 (2008), 1991–2002.
11. Ben-Haroush, A., Yogev, Y., Chen, R., Rosenn, B., Hod, M., Langer, O., The postprandial glucose profi le in the diabetic pregnancy. Am J Obstet Gynecol 191 (2004), 576–578.
12. Weisz, B., Shrim, A., Homko, C.J., Schiff, E., Epstein, G.S., Sivan, E., One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective study. J Perinatol 25 (2005), 241–324.
13. Hawkins, J.S., Casey, B.M., Lo, J.Y., Moss, K., McIntire, D.D., Leveno, K.J., Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. Obstet Gynecol 113 (2009), 1307–1312.
14. Goldberg, J.D., Franklin, B., Lasser, D., Jornsay, D.L., Hausknecht, R.U., Ginsberg-Fellner, F., et al. Gestational diabetes: impact of home glucose monitoring on neonatal birth weight. Am J Obstet Gynecol 154 (1986), 546–550.
15. Bancroft, K., Tuffnell, D.J., Mason, G.C., Rogerson, L.J., Mansfi eld M. A randomised controlled pilot study of the management of gestational impaired glucose tolerance. BJOG 107 (2000), 959–963.
16. Garner, P., Okun, N., Keely, E., Wells, G., Perkins, S., Sylvain, J., et al. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. Am J Obstet Gynecol 177 (1997), 190–195.
17. De Veciana, M., Major, C.A., Morgan, M.A., Asrat, T., Toohey, J.S., Lien, J.M., et al. Postprandial versus Preprandial Blood Glucose Monitoring in Women with Gestational Diabetes Mellitus Requiring Insulin Therapy. N Engl J Med 333 (1995), 237–241.
18. Sivan, E., Weisz, B., Homko, C.J., Reece, E.A., Schiff, E., One or two hours postprandial glucose measurements: are they the same ? Am J Obstet Gynecol 185 (2001), 604–607.
19. Haute Autorité de santé (HAS) Évaluation des dispositifs medicaux pour autosurveillance et autotraitement. Janvier 2007 http://www.has-sante.fr/publications.
20. Collège national des gynécologues et obstétriciens français (CNGOF). Supplémentation au cours de la grossesse. Recommandation pour la pratique Clinique. Décembre 1997. http://www.cngof.asso.fr/.
21. Reader, D.M., Medical nutrition therapy and lifestyle interventions. Diabetes Care 30:supp2 (2007), 188–193.
22. Peterson, C.M., Jovanovic-Peterson, L., Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes. Diabetes 40:Suppl 2 (1991), 172–174.
23. Major, C.A., Henry, M.J., De Veciana, M., Morgan MA. The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet Gynecol 91 (1998), 600–604.
24. Clapp JF 3rd. Effect of dietary carbohydrate on the glucose and insulin response to mixed caloric intake and exercise in both nonpregnant and pregnant women. Diabetes Care 199;21 Suppl 2:B107–12.
25. Moses, R.G., Barker, M., Winter, M., Petocz, P., Brand-Miller, J.C., Can a lowglycemic index diet reduce the need for insulin in gestational diabetes mellitus ? A randomized trial. Diabetes Care 32 (2009), 996–1000.
26. Scholl, T.O., Chen, X., Khoo, C.S., Lenders, C., The dietary glycemic index during pregnancy: infl uence on infant birth weight, fetal growth, and biomarkers of carbohydrate metabolism. Am J Epidemiol 159 (2004), 467–474.
27. Moses, R.G., Luebcke, M., Davis, W.S., Coleman, K.J., Tapsell, L.C., Petocz, P., et al. Effect of a low-glycemic-index diet during pregnancy on obstetric outcomes. Am J Clin Nutr 84 (2006), 807–812.
28. Fraser, R.B., Ford, F.A., Lawrence, G.F., Insulin sensitivity in third trimester pregnancy. A randomized study of dietary effects. Br J Obstet. Gynaeco 95 (1988), 223–229.
29. Fraser, R.B., Ford, F.A., Milner, R.D., A controlled trial of a high dietary fibre intake in pregnancy – -effects on plasma glucose and insulin levels. Diabetologia 25 (1983), 238–241.
30. Algert, S., Shragg, P., Hollingsworth, D.R., Moderate caloric restriction in obese women with gestational diabetes. Obstet Gynecol 65 (1985), 487–491.
31. Dornhorst, A., Nicholls, J.S., Probst, F., Paterson, C.M., Hollier, K.L., Elkeles, R.S., et al. Calorie restriction for treatment of gestational diabetes. Diabetes 40:Suppl 2 (1991), 161–164.
32. Knopp, R.H., Magee, M.S., Raisys, V., Benedetti, T., Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes 40:Suppl 2 (1991), 165–171.
33. Gin, H., Vambergue, A., Vasseur, C., Rigalleau, V., Dufour, P., Roques, A., Romon, M., et al. Blood ketone monitoring: a comparison between gestational diabetes and non-diabetic pregnant women. Diabetes Metab 32 (2006), 592–597.
34. Rizzo, T., Metzger, B.E., Burns, W.J., Burns, K., Correlations between antepartum maternal metabolism and child intelligence. N Engl J Med 325 (1991), 911–916.
35. Knopp, R.H., Magee, M.S., Raisys, V., Benedetti, T., Bonet, B., Hypocaloric diets and ketogenesis in the management of obese gestational diabetic women. J Am Coll Nutr 10 (1991), 649–667.
36. Ceysens, G., Rouiller, D., Boulvain, M., Exercise for diabetic pregnant women. Cochrane Database Syst Rev, 19, 2006, 3 CD004225.
37. Jovanovic-Peterson, L., Durak, E.P., Peterson, C.M., Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes. Am J Obstet Gynecol 161 (1989), 415–419.
38. Avery, M.D., Leon, A.S., Kopher, R.A., Effects of a partially home-based exercise program for women with gestational diabetes. Obstet Gynecol 89 (1997), 10–15.
39. Brankston, G.N., Mitchell, B.F., Ryan, E.A., Okun, N.B., Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus. Am J Obstet Gynecol 190 (2004), 188–193.
40. Bung, P., Artal, R., Khodiguian, N., Kjos, S., Exercise in gestational diabetes. An optional therapeutic approach?. Diabetes 40:Suppl 2 (1991), 182–185.
41. García-Patterson, A., Martín, E., Ubeda, J., María, MA, de Leiva, A, Corcoy, R, Evaluation of light exercise in the treatment of gestational diabetes. Diabetes Care 24 (2001), 2006–2007.
42. Nachum, Z., Ben Shlomo, I, Weiner, E, Shalev, E, Twice daily insulin versus four times daily insulin dose regimens for diabetes in pregnancy: randomized controlled trial. BMJ 319 (1999), 1223–1227.
43. Simmons, D., Thompson, C., Conroy, C., Scott, D.J., Use of insulin pumps in pregnancies complicated by type 2 and gestational diabetes in a multiethnic community. Diabetes Care 24 (2001), 2078–2082.
44. Mannino, Torlone.E.D., Insulin analogs and pregnancy: an update. Acta Diabetol 46 (2009), 163–172.
45. Edson, E.J., Bracco, O., Vambergue, A., Koivisto, V., Managing diabetes in pregnancy with insulin Lispro: a safe alternative to human insulin. Endocr Pract 3 (2010), 1–20.
46. Sumeet, R., Singh BSPhm, Fida, A., Avtar Lal, Changhua, Y., Zemin, B., et al. Effi cacity and safety of insulin analogues for the management of diabetes mellitus: a meta analysis. CMAJ 180 (2009), 385–397.
47. Buelke-Sam, J., Byrd, R.A., Hoyt, J.A., Zimmerman, J.L., A reproductive and development toxicity study in CD rats of LY275585, Lys (B28), Pro (B29) – human insulin. J Am Coll Toxicol 13 (1994), 247–260.
48. Kurtzhals, P., Schaffer, L., Sorensen, A., Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49 (2000), 999–1005.
49. Boskovic, R., Feig, D.S., Derewlany, L., Transfer of insulin Lispro across the placenta: in vitro perfusion studies. Diabetes Care 26 (2003), 1390–1394.
50. Holcberg, G., Tsadkin-Tamir, M., Sapir, O., Wiznizer, A., Segal, D., Polacheck, H., Transfer of insulin Lispro across the human placenta. Eur J Obstet Gynecol Reprod Biol 115 (2004), 117–118.
51. Wyatt, J.W., Frias, J.L., Hoyme, H.E., Jovanovic, L., Kaaja, R., Brown, F., et al. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy. Diabet Med 22 (2005), 803–807.
52. Jovanovic, L., Ilic, S., Pettitt, D.J., Metabolic and immunologic effects of insulin Lispro in gestational diabetes. Diabetes Care 22 (1999), 1422–1427.
53. Aydin, Y., Berker, D., Direktor, N., Is insulin Lispro safe in pregnant women: does it cause any adverse outcomes on infants or mothers. Diabetes Res Clin Pract 80 (2008), 444–448.
54. Bhattacharyya, A., Brown, S., Hughes, S., Vice, P.A., Insulin Lispro and regular insulin in pregnancy. Q J Med 95 (2001), 255–260.
55. Mecacci, F., Carignani, L., Cioni, R., Bartoli, E., Parretti, E., La Torre, P., et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non diabetic pregnant women. Eur J Obstet Gynecol 111 (2003), 19–24.
56. Di Cianni, G., Volpe, L., Ghio, A., Lencioni, C., Cuccuru, I., Benzi, L., et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with lispro or aspart insulin. Diabetes Care, 30, 2007, e11.
57. Ilic, S., Jovanovic, L., Pettit, D.J., Ohanessian, J., Bastyr, E.J., Treatment satisfaction with insulin therapy contributes to glucose control in gestational diabetes mellitus. Diabetes, 48(suppl. 1), 1999, 226.
58. Cypryk, K., Sobczak, M., Pertynska-Marczewska, M., Pregnancy complicationsand perinatal outcome in diabetic women treated with humalog (insulin Lispro) or regular human insulin during pregnancy. Med Sci Monit 10 (2004), PI24–PI32.
59. Pettitt, D.J., Ospina, P., Kolaccczynski, J.W., Jovanovic, L., Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care 26 (2003), 183–186.
60. Pettitt, D.J., Ospina, P., Howard, C., Zisser, H., Jovanovic, L., Effi cacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus. Diabet Med 24 (2007), 1129–1135.
61. Mathiesen, E.R., Kinsley, B., Amiel, S.A., Heller, S., Mc Cance, D., Duran, S., et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin Aspart versus human insulin in 322 pregnant women. Diabetes Care 30 (2007), 771–776.
62. Hod, M., et al. Safety and perinatal outcome in pregnancy: a randomized trial comparing insulin aspart with human insulin in 322 subjects with type 1 diabetes. Diabetes, 53(suppl 1), 2006, A417.
63. Singh, C., Jovanovic, L., Insulin Analogues in the Treatment of Diabetes in Pregnancy Obstetrics Gynecol. Clin N Am 34 (2007), 275–291.
64. Hoffmann, T., Horstmann, G., Stammberger, I., Evaluation of the reproductive toxicity and embryo toxicity of insulin glargine (LANTUS) in rats and rabbits. In J Toxicol 21 (2002), 181–189.
65. Slieker, L.J., Brooke, G.S., Dimarchi, R.D., Modifi cations in the B10 and B26-30 regions of the B chain of human insulin alter affi nity for the human IGF1 receptor more than for the insulin receptor. Diabetologia 40:suppl 2 (1997), S54–S61.
66. Stamberger, I., Bube, A., Durchfekd-Meyer, B., Donaubaurer, H., Troschau, G., Evaluation of the carcinogenic potential of insulin glargine (LANTUS) in rats and mices. Int J Toxicol 21 (2002), 171–179.
67. Pollex, E., Denice, S., Feig, M.D., Insulin Glargine Safety in Pregnancy. A transplacental transfer study. Diabetes Care 33 (2010), 29–33.
68. Price, N., Use of insulin glargine during pregnancy: a case-control pilot study. Br J Obstet Gynecol 114 (2007), 453–457.
69. Föyhönen-Alho, M., Tapani, R., Saltevo, J., Ekbald, U., Kaaja, R., Use of insulin glargine during pregnancy. Acta Obstet Gynecol 86 (2007), 1171–1174.
70. Tahrani, A.A., Varughese, G.I., Wilkins, J.D., Taylor, S.E., Hanna, F.W., Glargine in pregnant patients with type 1 diabetes. Diabet Med 25 (2008), 111–1112.
71. Imbergamo, M., Amato, M., Sciortino, G., Gambina, M., Accidenti, M., Criscimanna, A., et al. Use of Glargine in pregnant women with type 1 diabetes: a case-control study. Clin Ther 30 (2008), 1476–1484.
72. Gallen, I.W., Jaap, A., Roland, J.M., Chirayath, H.H., Survey of Glargine use in 115 pregnant women with type 1 diabetes. Diabet Med 25 (2008), 165–169.
73. Di Cianni, G., Torlone, E., Lencioni, C., Bonomo, M., Di Benedetto, A., Napoli, A., Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med 25 (2008), 993–996.
74. Lepercq, J., Jacqueminet, S., Hieronimus, S., Timsit, J., Grimaldi, A., Use of insulin glargine throughout pregnancy en 102 women with type 1 diabetes. Diabetes Metab 36 (2010), 209–212.
75. Graves, D.E., White, J.C., Kirk, J.K., The use of glargine insulin with gestational diabetes mellitus. Diabetes Care 29 (2005), 471–472.
76. Negrato, C.A., Rafacho, A., Negrato, G., Teixeira, M.F., Araujo, C.A., Vieira, L., et al. Glargine vs NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study. Diabetes Res Clin Pract 89 (2010), 46–51.
77. Persson, B., Stangenberg, M., Hansson, U., Gestational diabetes mellitus (GDM). Comparative evaluation of two treatment regimens, diet versus insulin and diet. Diabetes 34:suppl 2 (1985), 101–104.
78. Thompson, D.J., Porter, K.B., Gunnels, D.J., Prophylactic insulin in the management of gestational diabetes. Obstet Gynecol 75 (1990), 960–964.
79. Wechter, D.J., Kaufmann, R.C., Amankwah, K.S., Prevention of neonatal macrosomia in gestational diabetes by the use of intensive dietary therapy and home glucose monitoring. Am J Perinat 8 (1991), 131–134.
80. Botta, R.M., Di Giovanni, B.M., Cammilleri, F., Predictive factors for insulin treatment in women with diagnosis of gestational diabetes. Annali Dell'Istituto Superiore di Sanita 3 (1997), 403–406.
81. Buchanan, T.A., Kjos, S.L., Montoro, M.N., Wu, P., Madrilejo, N.G., Gonzales, M., et al. Use of fetal ultra-sound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care, 17, 1994, 2107.
82. Kjos, S.L., Schaefer-Graf, U., Sardesi, S., A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 24 (2001), 1904–1911.
83. Schaefer-Graf, U.M., Kjos, S., Fauzan, O., Bühling, K., Siebert, G., Bührer, C., et al. A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care 27 (2004), 297–302.
84. Bonomo, M., Cetin, I., Pisoni, M.P., Faden, D., Mion, E., Taricco E, et al Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intra unterine growth: a controlled randomized clinical trial. Diabetes Metab 30 (2004), 237–244.
85. Rossi, G., Osomigliana, E., Moschetta, M., Bottani, B., Barbieri, M., Vignali, M., Adequalte timing of fetal ultrasound to guide metabolic therapy in mild gestational diabetes mellitus. Results from a randomized study. Acta Obstet Gynecol Scand 79 (2000), 649–654.
86. Elliott, B.D., Langer, O., Schenker, S., Johnson, R.F., Insignifi cant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 165 (1991), 807–812.
87. Elliott, B.D., Shenker, S., Langer, O., Johnson, R.F., Prihoda, T., Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 171 (1994), 653–660.
88. Langer, O., Comway, D.L., Berkus, M.D., Xenakis, E.M.J., Gonzales, O., A comparaison of glyburide versus insulin in women with gestational diabetes mellitus. N Engl J Med 343 (2000), 1134–1138.
89. CRAT., – Centre de référence sur les agents, tératogènes. www.lecrat.org ( http://www.lecrat.org).
90. Nanovskaya, T, Transfer of metformin across the dually perfused human placenta lobule. Am J Obst Gyneco 195 (2006), 1081–1085.
91. Briggs, G., Freeman, R., Yaffe, S., Drugs in pregnancy and lactation. 7th ed., 2005, Lippincott, Philadelphia p. 1017–1020.
92. Informations sur le produit Precose. Bayer Corporationm 1997.
93. Bertini, A.M., Silva, J.C., Taborda, W., Becker, F., Lemos Bebber FR. Zucco Viesi JM. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med 33 (2005), 519–523.
94. Chan, L.Y.S., Yeung, J., Lau, T., Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fertil Steril 83 (2005), 955–958.
95. Research Triangle Park, NC:Glaxo Smith Kline, Avandia (rosiglitazone maleate) [prescribing information] 2005.
96. Moretti, E., Rezvani, M., Koren, G., Safety of glyburide for gestational diabetes. Ann Pharmacother 42 (2008), 483–490.
97. Coetzee, E.J., Jackson, W.P., The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1 (1985), 281–287.
98. Gilson, G., Murphy, N., Comparison of oral glyburide with insulin for the management of gestational diabetes mellitus in Alaska native women. Am J Obstet Gynecol, 187, 2002, S152.
99. Fines, V., Moore, T., Castle, S., A comparison of glyburide and insulin treatment in gestational diabetes mellitus on infant birth weight and adiposity (Abstract). Am J Obstet Gynecol, 189, 2003, S108.
100. Velasquez, M.D., Bolnick, J., Cloakey, D., Gonzalez, J.L., Curet, L.B., The use of glyburide in the management of gestational diabetes. Obstet Gynecol, 101(suppl), 2003, 888.
101. Chmait, R., Dinise, T., Moore, T., Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol 24 (2004), 617–622.
102. Conway, D.L., Use of glyburide for the treatment of gestational diabetes:the San Antonio experience. J Mat Fet Neonat Med 15 (2004), 51–55.
103. Jacobson, G.F., Ramos, G.A., Ching, J.Y., Kirby, R.S., Ferrara, A., Field DRComparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 193 (2005), 118–124.
104. Rochon, M., Rand, L., Roth, L., Gaddipati, S., Glyburide for the management of gestational diabetes:risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol 195 (2006), 1090–1094.
105. Nicholson, W., Bolen, S., Takacs Witkop, C, Neale, D, Wilson, L, Bass, E, Benefi ts and risks of oral diabetes agents compared with insulin in women with gestational diabetes. A systematic review. Obstet Gynecol 113 (2010), 193–203.
106. Chmait, R., Dinise, T., Moore, T., Prospective observational study to establish predictors of glyburide success in women with gestational diabetes. J Perinatol 24 (2004), 617–622.
107. Rowan, J.A., Hague, W.M., Gao, W., Batting, M.R., Moore, M.P., MIG Trial investigators. Metformin versus insulin for the treatment of gestational diabestes. N Engl J Med 358 (2008), 2003–2015.
108. Yogev, Y., Ben-Haroush, A., Chen, R., Rosenn, B., Hod, M., Langer, O., Undiagnosed asymptomatic hypoglycemia:diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 104 (2004), 88–93.
109. Alwan, N., Tuffnell, D.J., West, J., Treatments for gestational diabetes. Cochrane Database Syst Rev, 3, 2009 CD 003395.
110. Hague, W.M., Davoren, P.M., Oliver, J., Rowan, J., Contraindications to use of metformin. Metformine may be useful in gestational diabetes. BMJ, 326, 2003, 762.
111. Moore, L., Briery, C., Martin, R., Bofi ll, J., Morrison, J., Metformin and insulin in the management of gestational diabetes mellitus. J Repro Med 52 (2007), 1011–1015.
112. Dhulkotia, J.S., Fraser, R., Oral hypoglycemic agents vs insulin in management of gestational diabetes:a systematic review and metaanalysis. Am J Obstet Gynecol, 203, 2010 S47-1-9.
113. Silva, J.C., Bertini, A.M., Taborda, W., Glibenclamide in the treatment of gestational diabetes mellitus in a compared study to insulin. Arq Bras Endocrinol Metab 51 (2007), 541–546.
114. Ogunyemi, D., Jesse, M., Davidson, M., Comparison of glyburide versus insulin in management of gestational diabetes. N Engl J Med 358 (2008), 2003–2015.
115. Anjalakshi, C., Balaji, V., Balaji, M.S., Seshiah, V., A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian Women. Diabetes Res Clin Pract 76 (2007), 474–475.
116. Haute Autorité de santé (HAS). Rapport de synthèse sur le dépistage et le diagnostic du diabète gestationnel, juillet 2005. http://www.has-sante.fr/publications.
117. Langer, O., Yogev, Y., Most, O., Xenakis, E.M., Gestational diabetes:the consequences of not treating. Am J Obstet Gynecol 192 (2005), 989–997.
118. Hillier, T.A., Vesco, K., Pedula, K., Beil, T., Whitlock, E., Pettitt, D., Screening for gestational diabetes mellitus:a systematic review for the US Preventive Services Task Force. Ann Intern Med 148 (2008), 766–775.
119. Horvath, K., Koch, K., Jeitler, K., Matyas, E., Bender, R., Bastian, H., Effects of treatment in women with gestational diabetes mellitus:systematic review and meta-analysis. BMJ, 340, 2010, c1395.
120. Bartha, J.L., Martinez Del Fresno, P., Comino Delgado, R., Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol 182 (2000), 346–350.
121. O'Sullivan, J.B., Gellis, S.S., Dandrow, R.V., Tenney, B.O., The potential diabetic and her treatment in pregnancy. Obstet Gynecol 27 (1966), 683–689.